Covalent immobilization of cytochrome P450 BM3 (R966D/W1046S) on glutaraldehyde activated SPIONs

Bahrami, Atieh; Garnier, Alain; Larachi, Faïçal; Iliuta, Maria C.
October 2018
Canadian Journal of Chemical Engineering;Oct2018, Vol. 96 Issue 10, p2227
Academic Journal
Abstract: Selective hydroxylation of the C‐H bond of saturated hydrocarbon chains at room temperature is the signature of an invaluable biocatalyst, cytochrome P450 BM3 from Bacillus megaterium. Despite this remarkable ability, because of the enzyme's inherent low stability and dependence on electron supply by expensive NADPH, developing stable and economic BM3 systems is a challenging subject. To improve BM3 stability, facilitate its reuse, and reduce the process cost, this study suggests covalent immobilization of R966D/W1046S P450 BM3 on glutaraldehyde pre‐activated super paramagnetic iron oxide nanoparticles (SPIONs). This double mutant consumes less expensive cofactors like NADH and BNAH and its immobilization on magnetic support facilitates its separation and reuse. Free and immobilized enzyme performances were evaluated by 10‐pNCA hydroxylation and BM3 selectivity (hydroxylation at ω (1–3) positions of a fatty acid) was confirmed in a reaction involving myristic acid. The enzyme activity recovery was up to 60 % with 100 % enzyme binding efficiency. BM3‐SPIONs were easily separated from the reaction medium by applying a magnet, and recycled for 5 times, after which they could still present half of their initial activity. The enzyme storage stability was significantly improved: after one month of storage at 4 °C, the immobilized enzyme showed 80 % residual activity toward NADH while the soluble enzyme was inactive after a week. Binding an enzyme to fabricated SPIONs is a promising technique to increase enzyme stability and prevent downstream contamination in biocatalytic processes. In this context, BM3‐SPIONs can be a practical model system in cost‐effective large‐scale applications of such enzymes.


Related Articles

  • Laboratory evolution of a soluble, self-sufficient, highly active alkane hydroxylase. Glieder, Anton; Farinas, Edgardo T.; Arnold, Frances H. // Nature Biotechnology;Nov2002, Vol. 20 Issue 11, p1135 

    We have converted cytochrome P450 BM-3 from Bacillus megaterium (P450 BM-3), a medium-chain (C12-C18) fatty acid monooxygenase, into a highly efficient catalyst for the conversion of alkanes to alcohols. The evolved P450 BM-3 exhibits higher turnover rates than any reported biocatalyst for the...

  • A new cytochrome P450 system from Bacillus megaterium DSM319 for the hydroxylation of 11-keto-β-boswellic acid (KBA). Brill, Elisa; Hannemann, Frank; Zapp, Josef; Brüning, Gerit; Jauch, Johann; Bernhardt, Rita // Applied Microbiology & Biotechnology;Feb2014, Vol. 98 Issue 4, p1703 

    In the genome of Bacillus megaterium DSM319, a strain who has recently been sequenced to fully exploit its potential for biotechnological purposes, we identified a gene encoding the cytochrome P450 CYP106A1 as well as genes encoding potential redox partners of CYP106A1. We cloned, expressed, and...

  • A new Bacillus megaterium whole-cell catalyst for the hydroxylation of the pentacyclic triterpene 11-keto-β-boswellic acid (KBA) based on a recombinant cytochrome P450 system. Bleif, Sabrina; Hannemann, Frank; Zapp, Josef; Hartmann, David; Jauch, Johann; Bernhardt, Rita // Applied Microbiology & Biotechnology;Feb2012, Vol. 93 Issue 3, p1135 

    The use of cytochromes P450 for the regio- and stereoselective hydroxylation of non-activated carbon atoms in biotechnological applications reflects an efficient and cost-effective alternative in comparison to classical organic chemistry. The prokaryotic cytochrome P450 CYP106A2 from Bacillus...

  • Metabolism of polychlorinated dibenzo-p-dioxins by cytochrome P450 BM-3 and its mutant. Woro Sulistyaningdyah; Jun Ogawa; Qing-Shan Li; Raku Shinkyo; Toshiyuki Sakaki; Inouye, Kuniyo; Schmid, Rolf; Sakayu Shimizu // Biotechnology Letters;Dec2004, Vol. 26 Issue 24, p1857 

    The metabolism of polychlorinated dibenzo-p-dioxins by cytochrome P450 BM-3 fromBacillus megateriumand a mutant enzyme of it (AL4V; Ala74Gly, Phe87Val, Leu188Gln triple mutant) was examined. Both purified enzymes metabolized 1-monochloro-, 2,3-dichloro-, and 2,3,7-trichloro-dibenzo-p-dioxin, but...

  • P450camr, a cytochrome P450 catalysing the stereospecific 6-endo-hydroxylation of (1R)-(+)-camphor. Grogan, G.; Roberts, G. A.; Parsons, S.; Turner, N. J.; Flitsch, S. L. // Applied Microbiology & Biotechnology;Aug2002, Vol. 59 Issue 4/5, p449 

    Rhodococcus sp. NCIMB 9784 accumulated 6-endo-hydroxycamphor 3 when grown on (1R)-(+)-camphor 1 as sole carbon source. The structure of 3 has been unambiguously assigned for the first time using X-ray crystallography. A soluble cytochrome P450 hydroxylase, induced by growth on (1R)-(+)-camphor...

  • Construction of a thermostable cytochrome P450 chimera derived from self-sufficient mesophilic parents.  // Applied Microbiology & Biotechnology;Jul2007, Vol. 75 Issue 5, p1055 

    The P450 monooxygenases CYP102A1 from Bacillus megaterium and CYP102A3 from Bacillus subiilis are fusion flavocytochromes comprising of a P450 heme domain and a FAD/FMN reductase domain. This protein organization is responsible for the extraordinary catalytic activities making both...

  • Regulation of Drug-metabolizing Human Cytochrome P450s. Monostory, Katalin; Pascussi, Jean-Marc // Acta Chimica Slovenica;2008, Vol. 55 Issue 1, p20 

    Drug-metabolizing enzymes, primarily cytochrome P450 (P450) enzymes, play central role in biotransformation, detoxication and elimination of various, structurally diverse xenobiotics. The expression of P450s is controlled by specific receptors capable of sensing xenobiotics, including notably...

  • Inhibitors of Steroidal Cytochrome P450 Enzymes as Targets for Drug Development. Baston, Eckhard; Leroux, Fr�d�ric R. // Recent Patents on Anti-Cancer Drug Discovery;Jan2007, Vol. 2 Issue 1, p31 

    Cytochrome P450's are enzymes which catalyze a large number of biological reactions, for example hydroxylation, N-, O-, S- dealkylation, epoxidation or desamination. Their substrates include fatty acids, steroids or prostaglandins. In addition, a high number of various xenobiotics are...

  • In Vitro Inhibition of Rat CYP1A1 and CYP1A2 by Piceatannol, a Hydroxylated Metabolite of trans-Resveratrol. Chang, Thomas K.H.; Jie Chen; Chia-Ting Yu // Drug Metabolism Letters;Jan2007, Vol. 1 Issue 1, p13 

    Piceatannol and its parent compound, trans-resveratrol, decreased the in vitro catalytic activity of rat CYP1A1 and CYP1A2 by mixed inhibition. trans-Resveratrol was not a mechanism-based inactivator of rat CYP1A in vitro and the administration of this compound (50 mg/kg) to rats did not affect...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics